)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Tempest Therapeutics
Tempest Therapeutics (TPST) investor relations material
Tempest Therapeutics Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary21 Aug, 2026
Company overview and business model
Clinical-stage biotechnology company focused on developing chimeric antigen receptor T-cell (CAR-T) therapies targeting immunology and oncology indications.
Lead program TPST-4003 is a dual-targeting CD19/BCMA in vivo CAR-T candidate for blood cancers and solid tumors.
Expanded pipeline in February 2026 through acquisition of a dual-targeting CAR-T platform, including TPST-2003 for multiple myeloma and POEMS syndrome.
Mission centers on advancing clinical-stage candidates to address high unmet medical needs.
Financial performance and metrics
As of August 19, 2026, 16,539,767 shares of common stock were outstanding.
799,902 shares issuable upon exercise of stock options (weighted-average exercise price $36.81); 11,064,204 shares issuable upon exercise of warrants (weighted-average exercise price $12.09).
$8.2 million in gross proceeds estimated if all 8,000,000 shares are sold at $1.02 per share.
Use of proceeds and capital allocation
Proceeds from sales to Lincoln Park will be used for working capital and general corporate purposes.
Management has broad discretion over use of net proceeds.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tempest Therapeutics
- Shareholders will vote on easing voting thresholds and enabling action by written consent.TPST
Proxy filing - Strong clinical progress in CAR-T pipeline, but cash constraints and capital needs persist.TPSTQ2 2026
- Vote on reducing supermajority requirements adjourned; reconvenes August 17, 2026.TPSTProxy filing
- Proposal seeks to modernize governance by lowering voting thresholds and enabling written consent.TPSTProxy filing
- Lead in vivo CAR-T asset targets broad autoimmune and oncology markets with scalable, modular delivery.TPSTCorporate presentation
- Proposal seeks to replace supermajority voting with majority standards and allow written consent.TPSTProxy filing
- Biotech registers 2.4M shares for resale; proceeds from warrant exercises fund operations.TPSTRegistration filing
- Approval sought for major warrant-related share issuances to support liquidity and Nasdaq compliance.TPSTProxy filing
- Amezalpat improved median OS by six months and doubled response rates in first-line HCC.TPSTStudy Update
Next Tempest Therapeutics earnings date
AGM 202615 Sep, 2026
Tempest Therapeutics
Next Tempest Therapeutics earnings date
AGM 202615 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage